Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road to acceptance.

SAN ANTONIO, October 20, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, ...

Real-world use of antifibrotic therapy is associated with greater estimated survival in pulmonary fibrosis interstitial lung disease (PF-ILD).

Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a lung function test, say doctors ...

Fort St. John, B.C., residents needing respiratory testing can sigh a breath of relief, with a new diagnostic machine expected to come online soon at the local hospital. A body plethysmograph has now ...

At the LifeBridge Health ENT Sinus & Allergy Center, Dr. Alpen Patel helps patients get to the root of disrupted sleep. With dual training in ENT care and sleep medicine, he offers a well-rounded ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of blocking it to halt progression of the disease.

The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with idiopathic pulmonary fibrosis (IPF). 1 Nerandomilast's approval marks the first for a novel IPF ...

The one-minute sit-to-stand test (1MSTS) is a reliable way to assess your functional exercise capacity that’s simple to do and doesn’t cost a penny. In fact, all you need is a chair and – as the name ...

Chronic lung conditions like ILD, COPD, and lung cancer often go undiagnosed until late stages. Here’s what you need to know for early detection. (Image: Pexels) Silent lung conditions are a category ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

In this week’s edition of InnovationRx, we look at Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” Boehringer’s new lung drug, and more.